Harvard Bioscience (HBIO) Change in Cash (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Change in Cash of -$1.5 million for Q1 2026, down 205.42% year-over-year from $1.4 million in Q1 2025, and down 184.36% quarter-over-quarter from $1.8 million in Q4 2025.
Harvard Bioscience (HBIO) Change in Cash (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Change in Cash for 17 consecutive years, with -$1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 205.42% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at $1.6 million (up 20.22% YoY), while the FY2025 annual figure was $4.5 million, up 2674.86% from the prior year.
- Change in Cash fell to -$1.5 million in Q1 2026 per HBIO's latest filing, from $1.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $1.9 million in Q2 2025 and bottomed at -$2.4 million in Q1 2022.
- Historically, Change in Cash has averaged -$42529.4 across 5 years, with a median of -$207000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Cash plunged 378.2% — and 2025, when it surged 5235.71%.
- Harvard Bioscience's Change in Cash stood at -$636000.0 in 2022, then tumbled by 66.19% to -$1.1 million in 2023, then jumped by 56.39% to -$461000.0 in 2024, then soared by 489.8% to $1.8 million in 2025, then plunged by 184.36% to -$1.5 million in 2026.
- Business Quant data shows HBIO's Change in Cash at -$1.5 million in Q1 2026, $1.8 million in Q4 2025, and -$625000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 753.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -152.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -223.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -191.28 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 91.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -85.60 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -157.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 14.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 137.00 Mn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -595,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -595,000.00 |
| Mar 31, 2026 | -1.52 Mn |
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | -625,000.00 |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | -461,000.00 |
| Sep 30, 2024 | 521,000.00 |
| Jun 30, 2024 | -207,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -1.06 Mn |
| Sep 30, 2023 | 1.02 Mn |
| Jun 30, 2023 | 535,000.00 |
| Mar 31, 2023 | -719,000.00 |
| Dec 31, 2022 | -636,000.00 |
| Sep 30, 2022 | 885,000.00 |
| Jun 30, 2022 | -1.17 Mn |
| Mar 31, 2022 | -2.39 Mn |
| Dec 31, 2021 | 2.27 Mn |
| Sep 30, 2021 | -689,000.00 |